| Align Chiropractic Clinic Llc | |
|
1002 Diamond Rdg Suite 200 Jefferson City MO 65109-6896 | |
| (573) 635-4827 | |
| (573) 635-4361 |
| Full Name | Align Chiropractic Clinic Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1002 Diamond Rdg, Jefferson City, Missouri |
| Authorized Official Name and Position | Brandon Keith Johns (OWNER) |
| Authorized Official Contact | 8704895159 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Align Chiropractic Clinic Llc 1002 Diamond Rdg Suite 200 Jefferson City MO 65109-6896 Ph: (573) 635-4827 | Align Chiropractic Clinic Llc 1002 Diamond Rdg Suite 200 Jefferson City MO 65109-6896 Ph: (573) 635-4827 |
| NPI Number | 1366865263 |
|---|---|
| Provider Enumeration Date | 01/28/2014 |
| Last Update Date | 07/21/2022 |
| Medicare PECOS PAC ID | 5395978704 |
|---|---|
| Medicare Enrollment ID | O20140508001288 |
News Archive
The high head impact and concussion rates in football are of increasing concern, especially for younger players.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366865263 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (Missouri) | Primary |
| Provider Name | Brandon Keith Johns |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1578986477 PECOS PAC ID: 9537392048 Enrollment ID: I20140508001043 |
News Archive
The high head impact and concussion rates in football are of increasing concern, especially for younger players.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
› Verified 6 days ago
| Provider Name | Julie Motte |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1740941715 PECOS PAC ID: 2264828623 Enrollment ID: I20220412000572 |
News Archive
The high head impact and concussion rates in football are of increasing concern, especially for younger players.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
› Verified 6 days ago
| Provider Name | Dalton T Thurman |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1235866799 PECOS PAC ID: 8820471170 Enrollment ID: I20220818001874 |
News Archive
The high head impact and concussion rates in football are of increasing concern, especially for younger players.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
› Verified 6 days ago
| Provider Name | Thomas Kennedy |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1104522762 PECOS PAC ID: 7113399544 Enrollment ID: I20230217000602 |
News Archive
The high head impact and concussion rates in football are of increasing concern, especially for younger players.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
› Verified 6 days ago
| Provider Name | Victoria-lee Ngar-yan Moy |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1790168003 PECOS PAC ID: 4385009133 Enrollment ID: I20230429000283 |
News Archive
The high head impact and concussion rates in football are of increasing concern, especially for younger players.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
› Verified 6 days ago
| Provider Name | Melissa Victoria Clemons |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1114618741 PECOS PAC ID: 7911364757 Enrollment ID: I20230608003142 |
News Archive
The high head impact and concussion rates in football are of increasing concern, especially for younger players.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
› Verified 6 days ago
| Provider Name | Lindsay A Rehling |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1073397576 PECOS PAC ID: 3274996574 Enrollment ID: I20230905002356 |
News Archive
The high head impact and concussion rates in football are of increasing concern, especially for younger players.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
› Verified 6 days ago
| Provider Name | Alexandra Wendt |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1487371308 PECOS PAC ID: 3173978947 Enrollment ID: I20231013002160 |
News Archive
The high head impact and concussion rates in football are of increasing concern, especially for younger players.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
› Verified 6 days ago
News Archive
The high head impact and concussion rates in football are of increasing concern, especially for younger players.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Months into the coronavirus pandemic, older adults are having a hard time envisioning their "new normal."
Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.
› Verified 6 days ago
Spine Midwest, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 Saint Marys Medical Plz, Suite 301, Jefferson City, MO 65101 Phone: 573-634-4212 | |
Capital Region Corporate Health Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1500 Southwest Blvd, Ste C, Jefferson City, MO 65109 Phone: 573-632-5786 Fax: 573-632-5833 | |
Family Medicine Of Jefferson City, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1616 Southridge Dr, Suite #203, Jefferson City, MO 65109 Phone: 573-659-7300 Fax: 573-636-0555 | |
Ssm Health Wound Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2505 Mission Dr, Suite 210, Jefferson City, MO 65109 Phone: 573-681-3000 Fax: 573-659-2503 | |
Innovative Medical Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3218 W Edgewood Dr, Ste 500, Jefferson City, MO 65109 Phone: 949-696-6157 | |
Capital Region Physicians - Family Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 420 E High St, Jefferson City, MO 65101 Phone: 573-635-0916 Fax: 573-635-8812 | |
Capital Region Physicians - Southwest Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1500 Southwest Blvd, Ste D, Jefferson City, MO 65109 Phone: 573-632-5780 Fax: 573-632-5833 |